医疗保健类股正成为欧洲股市的拖累一系列不同风险已体现在其股价估值中且这类股票正变得愈发便宜。该板块对斯托克 600 指数

智通财经
Aug 06
医疗保健类股正成为欧洲股市的拖累一系列不同风险已体现在其股价估值中且这类股票正变得愈发便宜。该板块对斯托克 600 指数整体走势形成压制导致该指数回吐了当日大部分涨幅。瑞士企业表现不佳诺华和罗氏股价走低。美国关税的长期不确定性持续对该行业构成压力 —— 就在昨天特朗普总统还暗示可能会将关税税率提高至 250%。对于瑞士股市而言情况尤为严峻该国正与美国展开单独的关税博弈。美国国内推动降低药品价格的举措(这对行业运营模式构成威胁)也起到了不利作用。此外还需考虑美国整体医疗政策的不确定性官员们缩减 mRNA 疫苗资金就是最新例证。这些担忧正日益反映在行业估值中。一年前斯托克 600 医疗保健指数相对于基准指数的其他成分股存在相当大的溢价。如今该指数已处于折价状态。这种折价近期有所扩大而上周丹麦诺和诺德股价的大幅下跌更是加剧了这一情况。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10